PH can procure Covid-19 vaccine sans local clinical trials

By Ma. Teresa Montemayor

MANILA – The government can still procure Covid-19 vaccines from US-based pharmaceutical firm Moderna and other vaccine manufacturers even with the absence of local clinical trials, a health official said Wednesday.

In a virtual press briefing, Health Undersecretary Maria Rosario Vergeire said procurement is possible after the vaccines have undergone the country’s regulatory process and have been approved by the Food and Drug Administration (FDA).

β€œAng Moderna nakausap na sila ngΒ Department of Science and Technology [DOST] about a month ago andΒ ang kanilang talagangΒ intent is not to have a clinical trial in the Philippines but they would wantΒ na dun na sila papasok saΒ (Moderna had a talk with the DOST about a month ago and their intent was not to have a clinical trial in the Philippines but they would want to enter the) vaccine procurement,” Vergeire said.

On Monday, Moderna announced that its experimental Covid-19 vaccine was found almost 95 percent effective. Moderna’s clinical trial included more than 30,000 participants.

The drug maker Pfizer also announced Wednesday that its Covid-19 vaccine was 95 percent effective and had no serious side effects — the first set of complete results from a late-stage vaccine trial.

β€œBut if they (Moderna) do not intend,Β hindi po naman makakapag-stopΒ sa gobyerno para mag-procureΒ tayoΒ (this won’t stop our government from procuring) as long as they will go through the regulatory process,” Vergeire said.

She added it is important for the government to see the vaccine’s effects in its Phase 1, Phase 2, and Phase 3 clinical trials and for the local vaccine experts to evaluate the vaccine before it gets approved by the FDA.

As of 4 p.m. Wednesday, the number of patients who have recovered from coronavirus is 374,666 from the total 412,097 confirmed cases while 7,957 have died from the disease.Β (PNA)Β 

2 thoughts on “PH can procure Covid-19 vaccine sans local clinical trials

  • November 20, 2020 at 7:49 AM
    Permalink

    I just wanted some more information on the topic in this article. And it gives me plenty of unnecessary staff. I wish I got the details on compacom.com as I used to do before. Experiments are not always good. Sometimes an old trustful resource is worth sticking to it.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *